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Aromatic amino acid biosynthesis is dispensable for intramacrophagic 
 growth of Brucella suis, despite attenuation of an aroC mutant 
BACKGROUND 
A major characteristic of the intracellular pathogen Brucella suis is its ability to replicate in the macrophages of the host. Previous work using 
Signature-Tagged Mutagenesis (STM) on the genome of B. suis allowed isolation of an aroC (BR0428) mini-Tn5-mutant that was highly 
attenuated in cellular and murine models of infection, and characterization of the gene1,2. The authors concluded that in B. suis, the aromatic 
amino acids biosynthesis (shikimate) pathway encoded by the aro genes was necessary for intracellular and intramurine replication and that 
aro-mutants may be good candidates for vaccine development2.  However, no other genes of the pathway could be obtained by STM approach, 
and our group did not isolate any attenuated B. suis aro mutants by a large-scale Tn5-mutagenesis screen in macrophages3. In Salmonella sp., 
aroA mutation had been described to result in attenuation, and mutant strains have been used as vaccine and vaccine carrier strains.  
In our search for new targets of original anti-bacterial agents against Brucella sp., and based on the above-cited results obtained by Foulongne 
et al. with B. suis, we therefore focused on defined genes of the shikimate pathway to abolish intramacrophagic replication of Brucella sp. 
First, allelic exchange mutants of B. suis 1330 were constructed in aroC, encoding chorismate synthase, and in dhs (BR1013), the first gene of 
the pathway, encoding 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase. 
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(A) Growth and survival  of B. suis WT and of aroC and dhs 
in Balb/c spleens; arrow indicates i.p.-injected bacterial 
dosis. (B) Spleen weights of infected mice 
 Mutation of dhs does not affect intra-murine growth 
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Intracellular replication of B suis WT and (A) aroC, dhs, 
or (B) aroQ, aroE, aroK mutant strains  
in murine J774A.1 macrophage-like cells 
 Only the aroC mutant shows a 10-20-fold reduction 
Shikimate pathway of aromatic amino acids 
biosynthesis and positions of the genes 
inactivated in this study 
Culture of B. suis WT and of shikimate pathway mutants in 
minimal medium MM (A), and in MM supplemented with 
aromatic amino acids  Phe, Trp, Tyr (B) 
Addition of aromatic amino acids restores growth of 
 all mutants, despite reduced growth rate of aroC  
OBJECTIVE 
The aim of this study is to analyze the potential importance of 
aromatic amino acids biosynthesis via the shikimate pathway for 
intramacrophagic and intramurine replication of B. suis. The expected 
results will allow to evaluate the usefulness of enzymes encoding the 
different steps of this pathway as targets for novel anti-infective 
molecules.   
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CONCLUSIONS 
1) The shikimate pathway, leading to aromatic amino acids, folate and ubiquinone biosynthesis, is dispensable for intramacrophagic growth of B. 
suis and for its replication in the murine Balb/c model of infection: all tested mutants, except aroC, are not attenuated and replicate as the 
wild-type strain. These observations are consistent with the lack of isolation of attenuated mutants in this pathway during our large-scale 
Tn5-mutagenesis screen. 
2) The enzymes encoded by the shikimate pathway are not of interest as potential targets for novel anti-bacterial agents against Brucella sp.  
3) The observed attenuation of the aroC mutant is possibly due to toxic/growth inhibitory effect of the accumulated intermediate product 5-
O-(1-carboxyvinyl)-3-phosphoshikimate. 
